Navigation Links
Gammapod developed at University of Maryland School of Medicine targets early-stage breast cancer
Date:7/11/2013

An experimental innovation in cancer treatment from the Department of Radiation Oncology at the University of Maryland School of Medicine could provide a new, high-precision, noninvasive method of treating early-stage breast cancer. The GammaPod was invented by Cedric Yu, M.S., D.Sc., the Carl M. Mansfield Endowed Professor in the Department of Radiation Oncology, who patented the technology in 2006. Although the device has not yet been cleared by the Food and Drug Administration (FDA) to be used on patients, the manufacturer is actively seeking that approval and the department hopes to begin clinical trials as soon as October 2013.

Dr. Yu's research was funded initially by $3.5 million in Small Business Innovation Research grants from the National Institutes of Health (NIH). With support from the University of Maryland, Baltimore's Office of Research and Development (ORD), he founded a new company called Xcision Medical Systems, LLC, to pursue the development of the GammaPod. In 2010, Dr. Yu received the University System of Maryland's Entrepreneur of the Year award for his research leading to the development of the GammaPod. "I am so happy that this university encourages entrepreneurship and recognizes the importance of translational research that converts new knowledge into new products," says Dr. Yu.

The GammaPod enables a proven technology called stereotactic body radiation therapy (SBRT) to be used for breast cancer. SBRT has been used to successfully obliterate inoperable brain tumors and hard-to-reach lung and liver cancers. However, SBRT technology has not been applied to breast cancer. GammaPod system is the first device created specifically for the treatment of breast cancer. It is designed so that patients can receive external radiation treatments while lying on a comfortable treatment couch. The device uses tens of thousands beams of radiation from 36 rotating sources to focus the radiation to the tumor.

The affected
'/>"/>

Contact: Karen Robinson
karobinson@som.umaryland.edu
410-706-7590
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Geographic Information Systems aid health research in developed and developing countries
2. First Ever Over-the-Counter Organic Anti-Itch Ointment Developed by US Organic Group Corp.
3. Universities.com Recognizes Newly Developed Health Care Degree Programs as the Industry Continues to Grow
4. Mobile health app developed at UCLA simplifies process of choosing birth control method
5. hCGTreatments / Diet Doc hCG Diets and Weight Loss Plans Announce New, Uniquely Developed Diet Meal Plans That Take the Guesswork Out of Mealtime Preparation
6. US Drug Watchdog Now Urges Transvaginal Failure Victims To Call Them For The Contacts Of National Caliber Women Lawyers If They Have Developed Severe Complications
7. US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure Who Have Developed Severe Complications To Call Them For The Names Of Top Women Lawyers In The Nation
8. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
9. Food safety and bioterrorism defense may benefit from improved detection test developed at MU
10. New drug combination therapy developed to treat leukemia
11. Complete H2O Minerals Has Developed a Product for Women Using the Benefits of Liquid Vitamins and Minerals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Scotch Plains, NJ (PRWEB) , ... July 29, 2015 , ... ... , Dr. Andrzej Klos, a board-certified pediatrician for nearly 38 years, is motivated ... hard work, dedication and commitment to his profession shine alongside his many awards and ...
(Date:7/29/2015)... ... July 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. ... to Rock the Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac ... the Reformer ® by Potomac Pilates will continue to offer the same classes and ...
(Date:7/29/2015)... ... ... Ticket Down is a reliable source of authentic tickets for the international friendly ... international soccer schedule of matches played on American soil continues to grow each year. ... world’s greatest teams, Brazil, will travel to North America to compete with the United ...
(Date:7/29/2015)... Jacksonville, Fla. (PRWEB) , ... July 29, 2015 , ... ... due to record-setting precipitation levels this spring. And, where there is water, mold is ... and commercial property, offers tips for protecting against water and mold damage. Paul Davis ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley ... Ultherapy. For a limited time only, patients can get the complete treatment process with ... patients who prefer a non-invasive treatment and have loose or sagging skin. , ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2
... Common Human Disease has been chosen as one of ... Health (NIH) grant for Centers of Excellence to advance ... over five years. "We,re grateful for such ... epigenetic control affects disease," says the center,s director, Andrew ...
... no proof that procedure extends survival of cancer patients, , ... deciding to have a healthy breast removed after being diagnosed ... evidence to suggest that this practice is actually beneficial in ... published Sept. 28 in Cancer . , The ...
... clear, researchers say , , MONDAY, Sept. 28 (HealthDay ... 26 percent increased risk of developing atrial fibrillation, a ... overall incidence of atrial fibrillation was 3.6 percent among ... people without the metabolic condition was only 2.5 percent, ...
... A new study resolves a 130-year-old mystery over the developmental ... findings will appear in the October 5, 2009 issue of ... First described in 1875, Merkel cells are neuroendocrine cells ... to sensory neurons. In mice, they are mainly found in ...
... of Public Health and The Boston Globe finds 59% of Massachusetts ... was enacted in 2006, support it. A little more than one ... level of public support for the law has declined somewhat in ... 2008 to 59% in the current poll. The current number is ...
... Aromatase inhibitors, the same drugs that have buoyed ... side effects including joint pain so severe that many ... School of Medicine research, however, has uncovered patterns that ... of these symptoms sooner in order to increase their ...
Cached Medicine News:Health News:More Women Having Other Breast Removed 2Health News:More Women Having Other Breast Removed 3Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 2Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 3
(Date:7/29/2015)... 2015  Hologic, Inc. (NASDAQ: HOLX ) announced ... quarter ended June 27, 2015.  Quarterly revenues of $693.9 ... on a constant currency basis.  GAAP earnings per share ... $0.43 increased 16.2%. "Our third quarter financial ... building a company that can grow sustainably on both ...
(Date:7/29/2015)... July 29, 2015 WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology and ... and the United States ... for the second-quarter of 2015 after the New York ... will be Friday morning, August 14, 2015 Shanghai time). ...
(Date:7/29/2015)... SAN DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... ended June 30, 2015. For the second quarter of 2015, the ... per share, compared to a net loss of $13.4 million, or ... the six months ended June 30, 2015, the Company reported a ... compared to net loss of $25.2 million, or $0.35 loss per ...
Breaking Medicine Technology:Hologic Announces Financial Results for Third Quarter of Fiscal 2015 2Hologic Announces Financial Results for Third Quarter of Fiscal 2015 3Hologic Announces Financial Results for Third Quarter of Fiscal 2015 4Hologic Announces Financial Results for Third Quarter of Fiscal 2015 5Hologic Announces Financial Results for Third Quarter of Fiscal 2015 6Hologic Announces Financial Results for Third Quarter of Fiscal 2015 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 8Hologic Announces Financial Results for Third Quarter of Fiscal 2015 9Hologic Announces Financial Results for Third Quarter of Fiscal 2015 10Hologic Announces Financial Results for Third Quarter of Fiscal 2015 11Hologic Announces Financial Results for Third Quarter of Fiscal 2015 12Hologic Announces Financial Results for Third Quarter of Fiscal 2015 13Hologic Announces Financial Results for Third Quarter of Fiscal 2015 14Hologic Announces Financial Results for Third Quarter of Fiscal 2015 15Hologic Announces Financial Results for Third Quarter of Fiscal 2015 16Hologic Announces Financial Results for Third Quarter of Fiscal 2015 17Hologic Announces Financial Results for Third Quarter of Fiscal 2015 18Hologic Announces Financial Results for Third Quarter of Fiscal 2015 19Hologic Announces Financial Results for Third Quarter of Fiscal 2015 20Hologic Announces Financial Results for Third Quarter of Fiscal 2015 21Hologic Announces Financial Results for Third Quarter of Fiscal 2015 22Hologic Announces Financial Results for Third Quarter of Fiscal 2015 23Hologic Announces Financial Results for Third Quarter of Fiscal 2015 24Hologic Announces Financial Results for Third Quarter of Fiscal 2015 25WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9
The 5539-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Scan internal organs percutaneously while eliminating side lobe artifact....
... The 9115-5.0 transducer is ... imaging at the higher ... HST technology, this transducer ... when higher frequency abdominal ...
Medicine Products: